2m 2m 2m 2m 2m 2m 2m
MILESTONE PHARMA (MIST)
NASDAQ
$1.31+$0.03 (+2.58%)
Price as of Jun 03, 2026 7:58 PM EDT- $176.8MMarket Cap
- -21.89%1-Year Change
- BiotechnologyIndustry
MILESTONE PHARMA (MIST)
$1.31+$0.03 (+2.58%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.5M N/A | 0 -100.00% | 1.0M -80.00% | 5.0M -66.67% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.5M N/A | 0 -100.00% | 1.0M -80.00% | 5.0M -66.67% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -18.1M +26.13% | -14.4M -53.76% | -31.1M -22.04% | -39.8M +2.99% | |
Depreciation and Amortization Expense | 114,000 +8.57% | 105,000 +14.13% | 92,000 +3.37% | 89,000 -4.30% | |
Total Operating Expenses | 17.3M +3.18% | 16.7M +5.08% | 15.9M +1.36% | 15.7M +26.77% | |
Operating Profit | -62.1M +47.59% | -42.1M -31.09% | -61.1M +2.44% | -59.6M +38.47% | |
Interest Income | 2.9M -29.88% | 4.2M N/A | N/A N/A | N/A N/A | |
Interest Expense | -3.8M +7.18% | -3.6M +40.21% | -2.6M N/A | N/A N/A | |
Interest Income and Expense and Net | -918,000 -257.46% | 583,000 +122.83% | -2.6M N/A | 0 -100.00% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 4.0M +216.35% | 1.3M N/A | |
Income before Taxes | -62.1M +47.59% | -42.1M -31.09% | -61.1M +2.44% | -59.6M +39.18% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -63.1M +51.88% | -41.5M -30.44% | -59.7M +2.22% | -58.4M +36.25% | |
Net Income from Continuing Operations Applicable to Common | -63.1M +51.88% | -41.5M -30.44% | -59.7M +2.22% | -58.4M +36.25% | |
Basic EPS and Net Income | -0.75 +11.94% | -0.67 -51.80% | -1.39 +0.72% | -1.38 +35.29% | |
Diluted EPS and Net Income | -0.75 +11.94% | -0.67 -51.80% | -1.39 +0.72% | -1.38 +35.29% | |
Basic Weighted Average Shares | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted Weighted Average Shares | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 73.0M +188.56% | 25.3M +83.97% | 13.8M +80.20% | 7.6M -93.31% | |
Short-Term Investments | 32.9M -25.84% | 44.4M -15.05% | 52.2M -8.26% | 56.9M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 106.0M +52.03% | 69.7M +5.59% | 66.0M +2.20% | 64.6M -43.42% | |
Total Current Assets | 111.9M +51.40% | 73.9M +1.22% | 73.0M +1.71% | 71.8M -39.62% | |
Accumulated Depreciation | 406,000 +39.52% | 291,000 +52.36% | 191,000 +59.17% | 120,000 -49.79% | |
Property and Plant and Equipment and Net | 511,000 +159.39% | 197,000 -28.88% | 277,000 +7.78% | 257,000 +19.53% | |
Total Long-Term Assets | 511,000 +159.39% | 197,000 -28.88% | 277,000 +7.78% | 257,000 +19.53% | |
Total Assets | 113.6M +50.41% | 75.5M +0.36% | 75.2M +1.00% | 74.5M -37.85% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 14.0M +72.03% | 8.1M +12.46% | 7.2M +17.71% | 6.1M -9.39% | |
Total Long-Term Debt | 57.2M +7.20% | 53.4M +7.19% | 49.8M N/A | N/A N/A | |
Total Long-Term Liabilities | 83,000 -99.92% | 107.3M +7.64% | 99.7M +174.26% | 36.3M -31.95% | |
Total Liabilities | 71.8M +15.14% | 62.4M +6.67% | 58.5M +618.56% | 8.1M +12.22% | |
Retained Earnings | -430.6M +17.16% | -367.5M +12.73% | -326.0M +22.41% | -266.3M +29.09% | |
Total Stockholders Equity | 41.8M +217.71% | 13.1M -21.61% | 16.8M -74.72% | 66.3M -41.08% | |
Total Shares Outstanding | 106.2M +99.12% | 53.4M +59.35% | 33.5M -2.34% | 34.3M +14.68% | |
Cash Flow | |||||
Cash from Operating Activities | -49.0M +70.00% | -28.8M -37.86% | -46.4M -11.52% | -52.5M +57.92% | |
Capital Expenditures | 302,000 +815.15% | 33,000 -70.54% | 112,000 -58.82% | 272,000 N/A | |
Cash from Investing Activities | 11.2M +35.77% | 8.3M +74.16% | 4.8M +108.33% | -57.1M -181.61% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 85.5M +166.28% | 32.1M -32.79% | 47.8M +1,447.67% | 3.1M -38.91% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -4,019.40% N/A | N/A N/A | -6,109.80% +412.21% | -1,192.84% +315.40% | |
Return on Assets | -66.71% +21.08% | -55.09% -30.91% | -79.73% +32.69% | -60.09% +89.18% | |
Return on Equity | -229.65% -17.26% | -277.55% +93.26% | -143.61% +120.07% | -65.26% +94.71% | |
Revenue Growth | N/A N/A | -100.00% +25.00% | -80.00% +20.00% | -66.67% N/A | |
Current Ratio | 8.01 -11.99% | 9.10 -9.99% | 10.11 -13.59% | 11.70 -33.37% | |
Cash Ratio | 5.23 +67.74% | 3.12 +63.60% | 1.90 +53.08% | 1.24 -92.62% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow